These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel TP53 pathway influences the HGS-mediated exosome formation in colorectal cancer. Sun Y, Zheng W, Guo Z, Ju Q, Zhu L, Gao J, Zhou L, Liu F, Xu Y, Zhan Q, Zhou Z, Sun W, Zhao X. Sci Rep; 2016 Jun 17; 6():28083. PubMed ID: 27312428 [Abstract] [Full Text] [Related]
3. TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma. Broner EC, Tropé CG, Reich R, Davidson B. Hum Pathol; 2017 Feb 17; 60():180-187. PubMed ID: 27825812 [Abstract] [Full Text] [Related]
7. Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells. Inoue T, Hayashi Y, Tsujii Y, Yoshii S, Sakatani A, Kimura K, Uema R, Kato M, Saiki H, Shinzaki S, Iijima H, Takehara T. Sci Rep; 2021 Sep 30; 11(1):19524. PubMed ID: 34593902 [Abstract] [Full Text] [Related]
8. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer. Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX. Cancer Biomark; 2019 Sep 30; 26(1):69-77. PubMed ID: 31306108 [Abstract] [Full Text] [Related]
9. The regulation of exosome secretion: a novel function of the p53 protein. Yu X, Harris SL, Levine AJ. Cancer Res; 2006 May 01; 66(9):4795-801. PubMed ID: 16651434 [Abstract] [Full Text] [Related]
11. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. Li J, Chen Y, Guo X, Zhou L, Jia Z, Peng Z, Tang Y, Liu W, Zhu B, Wang L, Ren C. J Cell Mol Med; 2017 May 01; 21(5):838-847. PubMed ID: 28233416 [Abstract] [Full Text] [Related]
12. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ. Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715 [Abstract] [Full Text] [Related]
13. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. Amzallag N, Passer BJ, Allanic D, Segura E, Théry C, Goud B, Amson R, Telerman A. J Biol Chem; 2004 Oct 29; 279(44):46104-12. PubMed ID: 15319436 [Abstract] [Full Text] [Related]
16. The proto-oncogene PBF binds p53 and is associated with prognostic features in colorectal cancer. Read ML, Seed RI, Modasia B, Kwan PP, Sharma N, Smith VE, Watkins RJ, Bansal S, Gagliano T, Stratford AL, Ismail T, Wakelam MJ, Kim DS, Ward ST, Boelaert K, Franklyn JA, Turnell AS, McCabe CJ. Mol Carcinog; 2016 Jan 29; 55(1):15-26. PubMed ID: 25408419 [Abstract] [Full Text] [Related]
17. The regulation of the endosomal compartment by p53 the tumor suppressor gene. Yu X, Riley T, Levine AJ. FEBS J; 2009 Apr 29; 276(8):2201-12. PubMed ID: 19302216 [Abstract] [Full Text] [Related]
18. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer. Baassiri A, Nassar F, Mukherji D, Shamseddine A, Nasr R, Temraz S. Int J Mol Sci; 2020 Feb 19; 21(4):. PubMed ID: 32092975 [Abstract] [Full Text] [Related]
19. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion. Liu L, Meng T, Yang XH, Sayim P, Lei C, Jin B, Ge L, Wang HJ. Cancer Biomark; 2018 Feb 19; 22(2):283-299. PubMed ID: 29630521 [Abstract] [Full Text] [Related]
20. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer. Sun B, Li Y, Zhou Y, Ng TK, Zhao C, Gan Q, Gu X, Xiang J. J Cell Physiol; 2019 Feb 19; 234(2):1416-1425. PubMed ID: 30078189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]